Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Amino acid/auxin permease (AAAP) | ||||||
Sodium-coupled neutral amino acid transporter 9 (SLC38A9) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Truncation of SLC38A9 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that truncation of SLC38A9 leads to the increase of proline levels compared with control group. | |||||
Sodium-coupled neutral amino transporter 8 (SLC38A8) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexpression of SLC38A8 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC38A8 leads to the increase of proline levels compared with control group. | |||||
Solute carrier family 36 member 1 (SLC36A1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Overexpression of SLC36A1 | |||||
Induced Change | Proline concentration: increase (FC = 4.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC36A1 leads to the increase of proline levels compared with control group. | |||||
Solute carrier family 36 member 2 (SLC36A2) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Overexpression of SLC36A2 | |||||
Induced Change | Proline concentration: increase (FC = 2.1) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC36A2 leads to the increase of proline levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Mutation (G87V) of SLC36A2 | |||||
Induced Change | Proline concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (G87V) of SLC36A2 leads to the decrease of proline levels compared with control group. | |||||
Solute carrier family 38 member 2 (SLC38A2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Overexpression of SLC38A2 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC38A2 leads to the increase of proline levels compared with control group. | |||||
Solute carrier family 38 member 4 (SLC38A4) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Overexpression of SLC38A4 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC38A4 leads to the increase of proline levels compared with control group. | |||||
GPCR rhodopsin (GPCR-1) | ||||||
Adrenergic receptor beta-3 (ADRB3) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Agonist (CL-316,243) of Adrb3 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that agonist of ADRB3 leads to the increase of proline levels compared with control group. | |||||
GPCR secretin (GPCR-2) | ||||||
Glucagon receptor (GCGR) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[8] | ||||
Introduced Variation | Antagonist (GRA1) of GCGR | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20] | |||||
Details | It is reported that antagonist of GCGR leads to the increase of proline levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[9] | ||||
Introduced Variation | Knockout of Gcgr | |||||
Induced Change | Proline concentration: increase (FC = 2.3) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
Details | It is reported that knockout of GCGR leads to the increase of proline levels compared with control group. | |||||
Hydrolases (EC 3) | ||||||
Alpha-N-acetylglucosaminidase (NAGLU) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[10] | ||||
Introduced Variation | Knockout of Naglu | |||||
Induced Change | Proline concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Lysosomal storage diseases [ICD-11: 5C56] | |||||
Details | It is reported that knockout of Naglu leads to the decrease of proline levels compared with control group. | |||||
GTPase KRas (KRAS) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[11] | ||||
Introduced Variation | Overexpression of KRAS | |||||
Induced Change | Proline concentration: decrease (FC = 0.69) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Lung cancer [ICD-11: 2C25] | |||||
Details | It is reported that overexpression of KRAS leads to the decrease of proline levels compared with control group. | |||||
Leukotriene-C4 hydrolase (GGT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[12] | ||||
Introduced Variation | Knockdown (siRNA) of GGT1 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Renal cell carcinoma [ICD-11: 2C90] | |||||
Details | It is reported that knockdown of GGT1 leads to the increase of proline levels compared with control group. | |||||
Sulfatase sulf-1 (SULF1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[13] | ||||
Introduced Variation | Knockdown (shRNA) of SULF1 | |||||
Induced Change | Proline concentration: decrease (FC = 0.39 / 0.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
Details | It is reported that knockdown of SULF1 leads to the decrease of proline levels compared with control group. | |||||
Lyases (EC 4) | ||||||
Selenocysteine lyase (SCLY) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[14] | ||||
Introduced Variation | Knockout of Scly | |||||
Induced Change | Proline concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Scly leads to the decrease of proline levels compared with control group. | |||||
Oxidoreductases (EC 1) | ||||||
L-2-hydroxyglutarate dehydrogenase (L2HGDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[15] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of proline levels compared with control group. | |||||
Pore-forming PNC peptide (PNC) | ||||||
Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[16] | ||||
Introduced Variation | Knockout of TP53 | |||||
Induced Change | Proline concentration: decrease (Log2 FC=0.92) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockout of TP53 leads to the decrease of proline levels compared with control group. | |||||
Sodium:neurotransmitter symporter (SNF) | ||||||
Neurotransmitter transporter NTT4 (SLC6A17) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[17] | ||||
Introduced Variation | Knockdown (siRNA) of Slc6a17 | |||||
Induced Change | Proline concentration: decrease (FC = 0.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of Slc6a17 leads to the decrease of proline levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[17] | ||||
Introduced Variation | Overexpression of Slc6a17 | |||||
Induced Change | Proline concentration: increase (FC = 104.92) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Slc6a17 leads to the increase of proline levels compared with control group. | |||||
Sodium/chloride-dependent transporter XTRP3 (SLC6A20) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[18] | ||||
Introduced Variation | Overexpression of SLC6A20 | |||||
Induced Change | Proline concentration: increase (FC = 24) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC6A20 leads to the increase of proline levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Mutation (SNP T199M) of SLC6A20 | |||||
Induced Change | Proline concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (SNP T199M) of SLC6A20 leads to the decrease of proline levels compared with control group. | |||||
Transcription factor (TF) | ||||||
Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[19] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the increase of proline levels compared with control group. | |||||
R2R3-MYB (AN2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[20] | ||||
Introduced Variation | Overexpression of AN2 | |||||
Induced Change | Proline concentration: decrease (FC = 0.35) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of AN2 leads to the decrease of proline levels compared with control group. | |||||
Zinc finger protein (ZIN) | ||||||
Protein snail homolog 1 (SNAI1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[21] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of proline levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.